Abstract:Terminal differentiation of B cells depends on two interconnected survival pathways, elicited by the B-cell receptor (BCR) and the BAFF receptor (BAFF-R), respectively. Loss of either signaling pathway arrests B-cell development. Although BCR-dependent survival depends mainly on the activation of the v-AKT murine thymoma viral oncogene homolog 1 (AKT)/PI3-kinase network, BAFF/BAFF-R-mediated survival engages non-canonical NF-κB signaling as well as MAPK/extracellular-signal regulated kinase and AKT/PI3-kinase modules to allow proper B-cell development. Plasma cell survival, however, is independent of BAFF-R and regulated by APRIL that signals NF-κB activation via alternative receptors, that is, transmembrane activator and CAML interactor (TACI) or B-cell maturation (BCMA). All these complex signaling events are believed to secure survival by increased expression of anti-apoptotic B-cell lymphoma 2 (Bcl2) family proteins in developing and mature B cells. Curiously, how lack of BAFF- or APRIL-mediated signaling triggers B-cell apoptosis remains largely unexplored. Here, we show that two pro-apoptotic members of the ‘Bcl2 homology domain 3-only’ subgroup of the Bcl2 family, Bcl2 interacting mediator of cell death (Bim) and Bcl2 modifying factor (Bmf), mediate apoptosis in the context of TACI-Ig overexpression that effectively neutralizes BAFF as well as APRIL. Surprisingly, although Bcl2 overexpression triggers B-cell hyperplasia exceeding the one observed in Bim−/−Bmf−/− mice, Bcl2 transgenic B cells remain susceptible to the effects of TACI-Ig expression in vivo, leading to ameliorated pathology in Vav-Bcl2 transgenic mice. Together, our findings shed new light on the molecular machinery restricting B-cell survival during development, normal homeostasis and under pathological conditions. Our data further suggest that Bcl2 antagonists might improve the potency of BAFF/APRIL-depletion strategies in B-cell-driven pathologies.

Bclaf1 Regulates C-Flip Expression and Protects Cells from TNF-induced Apoptosis and Tissue Injury.

Influence of inhibitor of signal transduction on the cell apoptosis induced by TNF β

Linear Ubiquitination of Cflip Induced by LUBAC Contributes to TNFα-induced Apoptosis

Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1α under hypoxia

The progress of research on anti-apoptotic protein BFL1/hA1

TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members

An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

Bcl10 Plays A Critical Role in Nf-Kappa B Activation Induced by G Protein-Coupled Receptors

Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice

STAT1-Mediated Down-Regulation of Bcl-2 Expression Is Involved in IFN-γ/TNF-α–Induced Apoptosis in NIT-1 Cells

Phosphorylation of Bcl10 Negatively Regulates T-cell Receptor-Mediated NF-kappaB Activation.

Act1, a Negative Regulator in CD40- and BAFF-mediated B Cell Survival.

Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of Rnf31

The E3 Ubiquitin Ligase Itch Couples Jnk Activation to Tnf Alpha-Induced Cell Death by Inducing C-Flipl Turnover

BCLAF1 is a radiation-induced H2AX-interacting partner involved in γ H2AX-mediated regulation of apoptosis and DNA repair

NF-κB Signaling and Cell-Fate Decision Induced by a Fast-Dissociating Tumor Necrosis Factor Mutant.

Dysregulation of TNFα-induced Necroptotic Signaling in Chronic Lymphocytic Leukemia: Suppression of CYLD Gene by LEF1

Regulation of Bcl-Xl Expression and Fas Susceptibility in Mouse B Cells by CD40 Ligation, Surface IgM Crosslinking and IL-4.

Bcl10 can promote survival of antigen-stimulated B lymphocytes

Xaf1 can cooperate with TNFα in the induction of apoptosis, independently of interaction with XIAP

Zfra Affects TNF-mediated Cell Death by Interacting with Death Domain Protein TRADD and Negatively Regulates the Activation of NF-κB, JNK1, P53 and WOX1 During Stress Response